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ABSTRACT
Mammalian mitochondrial DNA (mtDNA) is a small, mater-
nally inherited genome that codes for 13 essential proteins in the
respiratory chain. Mature oocytes contain more than 150 000
copies of mtDNA, at least an order of magnitude greater than
the number in most somatic cells, but sperm contain only
approximately 100 copies. Mitochondrial oxidative phosphory-
lation has been suggested to be an important determinant of
oocyte quality and sperm motility; however, the functional
significance of the high mtDNA copy number in oocytes, and of
the low copy number in sperm, remains unclear. To investigate
the effects of mtDNA copy number on fertility, we genetically
manipulated mtDNA copy number in the mouse by deleting one
copy of Tfam, an essential component of the mitochondrial
nucleoid, at different stages of germline development. We show
that males can tolerate at least a threefold reduction in mtDNA
copy number in their sperm without impaired fertility, and in
fact, they preferentially transmit a deleted Tfam allele.
Surprisingly, oocytes with as few as 4000 copies of mtDNA
can be fertilized and progress normally through preimplantation
development to the blastocyst stage. The mature oocyte,
however, has a critical postimplantation developmental thresh-
old of 40 000–50 000 copies of mtDNA in the mature oocyte.
These observations suggest that the high mtDNA copy number in
the mature oocyte is a genetic device designed to distribute
mitochondria and mtDNAs to the cells of the early post-
implantation embryo before mitochondrial biogenesis and
mtDNA replication resumes, whereas down-regulation of
mtDNA copy number is important for normal sperm function.
early development, fertility, gamete biology, mitochondria,
mitochondrial DNA, mouse embryo, oocyte development,
sperm motility and transport
INTRODUCTION
Studies in a variety of species have revealed that the
mitochondrial content of mature female gametes is several
orders of magnitude greater than that in male gametes. These
observations led to the notion that the strict maternal
inheritance of mitochondrial DNA (mtDNA) is based on a
sex-specific discrepancy in mitochondrial content. Although
paternal inheritance of mtDNA can be observed in interspecific
crosses [1, 2], maternal germline transmission of mtDNA has
been faithfully conserved throughout metazoan evolution with
very few exceptions [3–5]. Selective destruction of paternal
mitochondria within the fertilized egg was demonstrated to
occur via ubiquitin-mediated degradation [6, 7]. In contrast to
the mitochondrial amplification that occurs during female
germline development, the down-regulation of key regulators
of mtDNA during spermatogenesis results in a decrease in
mtDNA copy number in sperm [8–11]. The evolutionary
impetus behind the conservation of high mtDNA copy number
in the female gamete and low mtDNA copy number in the male
gamete, however, remains unexplained.
Despite the abundance of mitochondria in mammalian
oocytes, the results of studies on mitochondrial morphology
suggest they have little capacity for oxidative phosphorylation
[12]. These mitochondria contain very few cristae, which are
the inner membrane invaginations that harbor the five multi-
meric protein complexes of the oxidative phosphorylation
system. Cristae increase the surface area of the inner
mitochondrial membrane and, therefore, are abundant in
mitochondria from highly aerobic and energy-demanding
somatic tissues.
Studies in frogs [11], mice [13, 14], rats [15], and pigs [16]
have shown that mtDNA replication does not occur during the
cleavage stages of embryogenesis, which would suggest that
the mitochondrial content of the oocyte is sufficient to maintain
vertebrate development until implantation and for the specifi-
cation of the germline in mammals [13]. It has therefore been
proposed that the increase of mitochondria and mtDNAs during
oogenesis is a genetic mechanism to ensure that a sufficient
number of organelles and genomes are present in cells of the
developing embryo once mtDNA replication restarts [17]. The
reasons for the suspension of mtDNA replication in the
preimplantation embryo remain unknown. Recent in vitro
studies have defined the minimal replisome as being composed
of a handful of nuclear-encoded mitochondrial factors,
including TFAM, GTF2H1 (TFB1), GTF2H2 (TFB2), POLG,
SSB, and PEO1 (TWINKLE). Originally named mtTFA,
TFAM is a basic protein of the HMG box family that is
thought to package mtDNA [18]. In vivo studies have shown
that TFAM levels control mtDNA copy number [19]. While it
appears as though mtDNA levels are controlled by TFAM, the
nature and origin of the signals that reinitiate mtDNA
replication, which is generally believed to resume after
implantation [16, 20], still elude us.
In the absence of mtDNA replication, one would predict
postimplantation embryonic cells to become largely depleted of
mtDNA by Embryonic Day (E) 7.5 to E8.5 in the mouse. From
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the initial levels of mtDNA in the cleavage-stage embryo and
the number of cells composing the embryo proper, embryonic
cells would be predicted to contain an estimated 18 copies of
mtDNA at E7.0 (4510 embryonic cells) and six copies at E7.5
(14 290 embryonic cells) [21]. It is therefore not surprising that
the targeted deletion of genes essential to the maintenance,
replication, and expression of mtDNA in the mouse (e.g., Tfam
KO) results in embryonic lethality between E8.5 and E10.5,
presumably because of mitochondrial insufficiency [22–24].
Knockout mouse models for other nuclear-encoded mitochon-
drial genes also appear to cause lethality around the same time
during embryogenesis [25–31].
Reports that high mitochondrial content can increase the
quality and competence of mature mammalian oocytes [32]
corroborate the notion of a critical developmental threshold,
which has been proposed to be on the order of 100 000
mitochondria in humans [33] and mice [14]. In humans,
maternal age and oocyte mtDNA copy number have been
reported to be negatively correlated [34], and oocytes retrieved
from patients with ovarian insufficiency contain, on average,
threefold fewer copies of mtDNA [35]. Indeed, a link between
inherited mtDNA depletion syndromes and female infertility
[36, 37] was established when it was noticed that inherited
neurodegenerative disorders caused by a dominant mutation in
the polymerase gamma gene [38] also co-occurred with
premature ovarian failure [36, 37]. Reduced fertility has also
been documented in female mice with a proofreading-deficient
version of polymerase gamma [39]. It is therefore becoming
clear that mtDNA copy number in the oocyte, embryo, and
perhaps, even the sperm [40] may be playing a substantial role
in the success of sexual reproduction.
In the present study, we have investigated the role of
mtDNA copy number in male and female fertility. We created
germline-specific heterozygous Tfam knockout mice to reduce
mtDNA content in ovulated oocytes to determine if reduced
mtDNA content in these oocytes affected fertilization. By
transferring the resulting low-mtDNA copy number embryos
into pseudopregnant females, we empirically determine the
oocyte and embryonic mtDNA content necessary for embry-
onic development. In so doing, we also show that oocytes with
mtDNA levels below the normal biological range can be
successfully fertilized, proceed normally through preimplanta-
tion development, but die during organogenesis. Conversely,
we report that similar reductions in mtDNA copy number in the
germline of males cause no obvious defects in fertility, sperm
motility, or sperm count.
MATERIALS AND METHODS
Transgenic Mice and Genotyping
All investigations were conducted in accordance with the Guide for the
Care and Use of Agricultural Animals in Agricultural Research and Teaching
and the McGill University Animal Care Committee ethical guidelines for the
care and use of laboratory animals. Heteroplasmic floxed Tfam mice were
generated by crossing previously described OG2-BALB/NZB females [12] to
Tfamfl/fl (official allele symbol, Tfamtm1Lrsn) males [22]. F1 females were then
backcrossed to Tfamfl/fl males for five generations to generate heteroplasmic
floxed Tfam females that also carried the GOF18deltaPE transgene, henceforth
termed Tfamfl/flOG2-BALB/NZB. To generate heterozygous Tfamþ/OG2-
BALB/NZB animals, we crossed males carrying the TNAP-Cre recombinase
transgene [41] to Tfamfl/flOG2-BALB/NZB females. Genotyping for the
presence of the GOF18deltaPE transgene [12] and the Alpl-Cre recombinase
transgene [41] was performed as previously described. We used previously
published methods for Tfam genotyping of offspring [42]. We determined the
proportions of Tfam alleles using a modified last-cycle hot approach to
incorporate gamma [a-32P]dCTP into the PCR amplicons generated during the
last amplification cycle. Amplicons from floxed (437-bp), wild-type (404-bp),
and null (327-bp) alleles were separated by gel electrophoresis on 12%
acrylamide gels and quantified by densitometry. Radioactive intensity was
normalized to amplicon length, and allelic ratios were normalized
to heterozygous Tfamfl/þ controls. The analysis of mtDNA heteroplasmy was
performed as previously described [12].
Cleavage-Stage Embryo Isolation and Blastomere Biopsy
Isolation of cleavage-stage embryos and oocytes from mice was performed
as previously described [12]. Blastomeres from 6- to 8-cell uncompacted and
compacting embryos were isolated as previously described [43]. Briefly, each
embryo was incubated for 5 min in Ca2þ- and Mg2þ-free medium (Cook
Canada, Inc.) to allow the blastomeres to decompact. The zona pellucida was
removed using acid Tyrode solution (pH 2.5; Sigma) and the cells washed
through three drops of PBS containing 4 mg/ml of bovine serum albumin
(BSA; Sigma). The blastomeres were then disaggregated using a sterile pulled-
glass pipette and individually pipetted into tubes containing a final volume of
10 ll of PBS with 0.01% BSA for lysis, because downstream quantitative real-
time PCR (Q-PCR) applications for the quantification of mtDNA were
incompatible with original lysis solutions [43].
Embryo Culture and Transfer into Surrogate Recipient
Biopsied embryos were cultured until the blastocyst stage and then
transferred to the uteri of pseudopregnant recipient females as previously
described [44]. Briefly, recipient females were mated with vasectomized CD1
males (Charles River), and the day of plug was considered to be Day 1.
Heterozygous Tfam females used for embryo-transfer experiments were mated
with vasectomized males, and then from two to six blastocysts were transferred
into each uterine horn on the morning of Day 4. Before transfer, compacted
morulae were cultured in 10-ll droplets of bicarbonate-buffered KSOM
medium under mineral oil (Sigma) at 378C in a humidified atmosphere of 5%
CO
2
in air. After 24 h of incubation, blastocyst-stage embryos (as judged by the
formation of blastocoelic cavity) were selected and transferred as described
above. Uteri were recovered at E10.5 or E12.5, and embryos were analyzed to
assess developmental progression.
Sperm Collection for Motility Analyses
Twelve wild-type Tfam (Tfamþ/þ and Tfamfl/þ) mice and 12 heterozygous
(Tfamþ/ or Tfamfl/) mice at 4 mo of age were used for the analysis of male
fertility. All mice were weighed, anesthetized with isoflurane, and euthanized
by cervical dislocation.
Sperm motility was assessed as previously described [45]. Briefly, the
caudal region of the right epididymidis of each mouse was placed in a
microcentrifuge tube and stored at808C for subsequent sperm count analyses
(see Sperm Counts). The left caudal epididymidis of each animal was clamped
both proximally and distally, excised, and rinsed in a 35-mm plastic Petri dish
containing prewarmed Hanks medium M199 (Invitrogen Canada, Inc.)
supplemented with 0.5% BSA at 378C. The cauda was then transferred to a
fresh Petri dish, unclamped, and pierced at several points with the tip of a
surgical dissection blade along the longitudinal axis of the cauda, releasing
sperm into the medium. The cauda was removed and the Petri dish placed at
378C for 5 min to allow sperm to disperse. Subsequently, an aliquot of the
sperm suspension was appropriately diluted with medium and placed into an
80-mm 2X-CEL glass slide chamber (Hamilton-Thorne Biosciences). Approx-
imately 30 scans per slide per individual mouse were analyzed with a
Hamilton-Thorne IVOS automated semen analyzer (Hamilton-Thorne Biosci-
ences) using the default settings recommended by the manufacturer. Statistical
and correlation analyses as well as power tests of motility data were done using
the Statistica Data Miner for Windows, Version 7.1 (Statsoft, Inc.). The
following parameters of sperm motility were measured: average path velocity
(VAP), progressive velocity (VSL; i.e., average velocity measured in a straight
line from beginning to end of track), track speed (VCL; i.e., average velocity
measured over the actual point to point track followed by the cell), amplitude of
lateral head displacement (i.e., average displacement path corresponding to
average of the sperm track width), beat cross frequency (i.e., the frequency with
which the sperm head crosses over the sperm average path in either direction),
average value of the VSL:VAP ratio (measures the departure of the cell path
from a straight line), and average value of the VSL:VCL ratio (measures the
departure of the cell track from a straight line).
Sperm Counts
Sperm counts were determined as previously described [45]. Briefly, the
frozen right caudal epididymidis of each animal was thawed and homogenized
in a 50-ml conical tube containing 10–20 ml of distilled water. A 100-ll aliquot
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of the resulting homogenate was diluted with 100 ml of distilled water in a 1.5-
ml microcentrifuge tube coated with IDENT fluorescent dye (Hamilton-Thorne
Biosciences) and incubated at room temperature for 2 min. The suspension was
mixed, and a 5-ml aliquot was placed in a 20-mm sperm analysis chamber (2X-
CEL; Hamilton-Thorne Biosciences) and quantified with the IVOS semen
analyzer.
Mitochondrial DNA Quantification
Absolute mtDNA copy number measurements made in cleavage-stage
embryos and oocytes were performed as previously described [12]. Relative
quantification of mtDNA levels measured in sperm and male reproductive
tissues was determined by the ratio of the mitochondrial ND2 (mt-Nd2) gene
(DQ874614) to the single-copy, nuclear-encoded B2m (beta-2-microglobulin)
gene (NM_009735). Q-PCR reactions using B2m forward (50-TGTCAGA
TATGTCCTTCAGCAAGG-3 0) and reverse (5 0-TGCTTAACTCTG
CAGGCGTATG-30) primers were performed using DNA Faststart Master
Plus SYBR Green (Roche) on the Rotorgene 3000 (Corbett) using the
following protocol: 35 cycles, denaturation at 958C for 10 sec, annealing at
628C for 15 sec, and extension at 728C for 20 sec. Melt-curve analyses reported
on the specificity of the PCR products that were amplified. Post-run analyses of
the amplification efficiency were performed and corrected using the Rotorgene
software and LINREGPCR programs [46]. Serial dilution inputs for both the
ND2 and B2M Q-PCR reactions were used to ensure identical amplification
efficiencies, after which ratios for each sample were generated using arbitrary
concentration units. Replicate serial dilutions within the linear range for both
nuclear and mitochondrial genes were used to calculate relative mtDNA copy
number.
Statistical Testing
Chi-square tests were used to assess the difference in survival rates between
low copy number Tfamþ/ embryos and high copy number Tfamþ/ embryos
and between the number of wild-type and deleted Tfam alleles segregating in
testcrosses and present in sperm samples from Tfamþ/ males. Groups
producing P values of less than 0.05 were considered to be significantly
different. Normality of mtDNA copy number distributions was assessed using
the Shapiro-Wilk test.
RESULTS
Defining the Developmental Threshold of mtDNA
in the Early Embryo
Although a critical threshold of oocyte mtDNA content
(;100 000 copies) is thought to be required for fertilization and
embryonic development in mammals [14, 32, 35, 47], to our
knowledge no direct experimental evidence supports this
contention. To determine the critical developmental threshold,
we first investigated the biological variability in mtDNA
content in the mature oocyte of the mouse. To avoid potential
contamination by sperm and cumulus cells, we measured the
absolute mtDNA copy number in 2-, 4-, and 8-cell embryos
generated by natural-timed matings between proven breeders.
Because we did not find significant differences in mtDNA copy
number between fertilized oocytes and cleavage-stage embry-
os, we chose to use cleavage-stage embryos as proxies for
mature oocytes. In the absence of preimplantation mtDNA
replication, the levels of mtDNA in the mature oocyte
accurately reflect those of the cleavage-stage embryo [48]. In
addition, damaged or poor-quality oocytes, unable to perform
the initial cleavage divisions and destined for destruction, are
excluded from these analyses. It is worthwhile noting that we
did not observe any correlation between the mtDNA content of
developing preimplantation embryos and the rate of cleavage.
We did not superovulate before copulation, because it has been
reported that gonadotropins (e.g., human chorionic gonadotro-
pin) can inflate ATP levels and mtDNA copy number in
rodents. We analyzed 219 cleavage-stage embryos and found
an average of 161 000 (SD, 73 000) copies of mtDNA (median,
154 000 copies; range, 11 000–428 000 copies) (Fig. 1). Further
analysis showed an asymmetry in the distribution of copy
number in these embryos (skewness, 0.534; kurtosis, 0.317),
with only 3 out of 219 embryos (1.4%) from this nonnormal
distribution (P , 0.0001) containing fewer than 40 000 copies
and 95% (210 out of 219) of embryos containing between
50 000 and 330 000 copies (Fig. 1).
Oocyte Fertilization and Cleavage Are Not Affected by Low
mtDNA Content
Previous reports linking oocyte competence and mitochon-
drial content suggested that low mtDNA content could prevent
fertilization [49]. We sought to determine whether low mtDNA
levels in the oocyte could directly affect its ability to be
fertilized by sperm. As a source of oocytes containing
decreased amounts of mtDNA, we used a heteroplasmic mouse
model in which we deleted a single copy of the Tfam gene
using Cre recombinase-mediated germline excision of a floxed
Tfam allele. This was accomplished by crossing Alpl-Creþ/þ
males to Tfamfl/fl heteroplasmic females. Our Tfamþ/– females,
generated by crossing F1 Tfamfl/þ;Alpl-Creþ mothers to wild-
type males, themselves generated cleavage-stage embryos that
contained an average of 69 000 copies of mtDNA (;40% of
control) (Fig. 2A), which is similar to the previously reported
decrease in mtDNA content observed in somatic tissues of
heterozygous Tfam adults and embryos. Reproduction in both
males and females was normal, with normal litter sizes and
numbers obtained in reciprocal testcrosses as well as
intercrosses. However, in females for which germlines were
made heterozygous for Tfam by Zp3-Cre recombinase-
mediated excision during folliculogenesis (Tfamfl/þZp3-Creþ),
we observed dramatically reduced female fertility. Zp3-Cre
recombinase is active exclusively during oocyte growth in the
female germline. At this stage of development, replication of
mtDNA from a subgroup of genomes must regenerate the
160 000 mtDNA copies present in the mature oocyte. Of 49
females paired with proven male breeders in timed matings,
only three produced viable litters, despite the production of
distinct vaginal plugs being observed in the vast majority of
paired females the day after setting up the timed mating.
Interestingly, these females generated 2-cell zygotes that
contained an average of 18 000 copies of mtDNA per embryo
(;11% of control) (Fig. 2B). As predicted, we did not observe
male infertility in Tfamfl/þ;Zp3-Creþ male littermates. Because
the number of cleavage-stage embryos isolated from these
FIG. 1. Distribution of mitochondrial DNA copy number in wild-type,
heteroplasmic, cleavage-stage embryos. Embryos contain an average of
161 000 (SD, 73 000) copies of mtDNA (range, 11 000–428 000 copies; n
¼ 219).
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same infertile Tfamfl/þ;Zp3-Creþ females (mated to fertile
males) was not significantly different than control (data not
shown), it was not possible to attribute the observed infertility
to either aberrant ovulation or oocyte fertilization. We
examined mtDNA copy number in another knockout mouse
model for Mpv17, a gene that when mutated in humans causes
an autosomal recessive, infantile, liver-specific mtDNA
depletion syndrome [50]. We did not observe a decrease in
mtDNA copy number in embryos from Mpv17/ females (n¼
9), which generated offspring and litter sizes comparable to
those of controls (data not shown). Unexpectedly, Cox10þ/
(but not Cox10fl/þ;Zp3-Creþ, or Cox10 fl/þ;Zp3-Cre) females
exhibited a 2.5-fold increase in mean mtDNA copy number in
cleavage-stage embryos (Fig. 2C), but this did not affect litter
size or the number of ovulated oocytes (data not shown). Like
most other genes coding for factors required in the proper
assembly of the respiratory chain complexes, homozygous
deletion of Cox10 in the mouse is embryonically lethal [30].
We occasionally observed developmental asynchrony in a
minor fraction of embryos isolated between 0.5 and 3.5 days
postcoitus (dpc), both from wild-type and all-knockout
females, but the rate of progression through cleavage did not
correlate with mtDNA copy number. Taken together, these data
argue strongly that low mtDNA copy number does not
significantly impede either fertilization or preimplantation
development in the mouse.
Low mtDNA Copy Number Impairs Postimplantation
Development
To determine whether decreases in postimplantation viability
and live birth number were directly related to the amount of
mtDNA inherited from the oocyte, we transferred Tfam
blastocysts into pseudopregnant wild-type females, and we
assessed the developmental outcome of these low mtDNA copy
number embryos at either 10.5 or 12.5 dpc. Fertilized oocytes
and cleavage-stage embryos from Tfamþ/ females contain
approximately 69 000 copies of mtDNA (Fig. 2A). However,
because the distribution of mtDNA copy number in Tfamþ/
embryos overlaps the distribution observed in wild-type
embryos (Fig. 2), it was not possible to simply transfer
Tfamþ/ embryos; we needed to determine the individual
mtDNA content of these low copy number blastocysts before
transfer. To do so, we quantified mtDNA copy number by Q-
PCR from single blastomeres that were biopsied from 8-cell
Tfamþ/ embryos. This allowed us to estimate the total
embryonic content of mtDNA in these embryos, which we
then cultured overnight before performing the transfer (Fig. 3).
Serving as controls, higher copy number Tfamþ/ embryos were
transferred to the right uterine horn, while low copy number
embryos were transferred to the left, allowing us to distinguish
an implantation failure unrelated to embryonic content of
mtDNA. We transferred 15 high copy number Tfamþ/ embryos
and 19 low copy number Tfamþ/ embryos into four surrogate
females (Fig. 3). Only 2 out of 19 (11%) low copy number
embryos developed normally (including one out of two low
copy number embryos in group 7) compared to 9 out of 15 high-
copy number embryos (60%). In our hands, we obtain an 80%
survival rate for 2.5-dpc embryo transfers performed without
biopsy of blastomeres and overnight culture, which is not
significantly different from the survival rate measured in the
Tfamþ/ embryos serving as controls (chi-square test, P ¼
0.528). However, we observed a dramatic reduction in
postimplantation embryonic viability in the low copy number
Tfamþ/ embryos (chi-square test, P , 0.001) (Fig. 4). From
these studies, we conclude that an oocyte mtDNA content
below approximately 50 000 copies (i.e., the low end of the
biological distribution found in wild-type oocytes) is unlikely to
progress normally through postimplantation development.
FIG. 2. Distribution of mitochondrial DNA copy number in germline
knockout embryos: comparison of mtDNA copy number in wild-type
(WT), heteroplasmic, cleavage-stage embryos from Tfamþ/ heteroplasmic
females (A), Tfamfl/þ;Zp3-Creþ heteroplasmic females (B), and Cox10þ/
females (C). Embryos from Tfamþ/ heteroplasmic females (A; black)
contained an average of 69 000 copies of mtDNA (n¼ 74), whereas those
from Tfamfl/þ;Zp3-Creþ heteroplasmic females (B; black) contained an
average of 18 000 copies (n¼ 96). Embryos from heteroplasmic Cox10þ/
females (C; black) contained an average of 424 000 copies of mtDNA (n¼
54).
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Reduction in mtDNA Content in Sperm Does Not
Affect Function
We failed to observe overt signs of infertility, such as
inability to copulate, absence of vaginal plugs, or decreased
litter sizes, in Tfamþ/ males. However, the suggested link
between mtDNA and male fertility reported in asthenozoo-
spermic and oligozoospermic humans [51, 52] and in mice
carrying large-scale deletions of mtDNA [53] led us to test
whether a more subtle functional impairment could manifest in
the sperm of Tfamþ/ males, which contain significantly less
mtDNA than controls (Student t-test, P , 0.001). We assessed
several standard measures of motility in sperm isolated from
the caudal epididymis of Tfam heterozygous and wild-type
littermates and observed no significant differences (Fig. 5A).
We also failed to detect differences in sperm count in these
animals, despite a threefold relative reduction in mtDNA
content. It is perhaps worthwhile to note that we observed
greater variability in both sperm motility and sperm count
among wild-type males born to mothers of different nuclear
genetic backgrounds than between wild-type and Tfamþ/
littermates (data not shown).
To exclude the possibility that the normal sperm function
and count resulted from an allelic imbalance—namely, the
overrepresentation of wild-type sperm—we performed quanti-
tative genotyping of Tfam alleles on DNA extracted from
caudal epididymal sperm and the male reproductive tract
(epididymis and testes). Unexpectedly, we observed a
significant allelic imbalance in favor of the deleted Tfam allele
in the sperm (Fig. 5B) that was reflected in offspring generated
from recessive testcrosses between heterozygous Tfam males
and wild-type females. Live offspring generated from seven
separate recessive testcrosses demonstrated that of 114 total
inherited Tfam alleles, 80 of these alleles were Tfam
(compared to an expected 62 alleles). In other words, rather
than the mendelian prediction of 50%, the offspring inherited
the deleted allele from a heterozygous father approximately
65% of the time. When the reciprocal testcross of wild-type
males to heterozygous females was performed, the deleted
allele was inherited at a frequency of 94 alleles out of a
FIG. 3. Defining the critical developmental threshold of mtDNA copy number. Mitochondrial DNA quantification of biopsied blastomeres from
cleavage-stage (8-cell) embryos was performed to estimate mtDNA content in cleavage-stage embryos before transfer to surrogate recipients. Embryos
were grouped into low-copy or high-copy groups and then transferred to separate uterine horns of the surrogate. In some cases, it was possible to assign
copy number in individual embryos by examining the heteroplasmy measurements in the developed postimplantation embryo. Normal, stage-appropriate
morphological development was scored as positive; aborted and developmentally delayed embryos were scored as negative. All images were acquired
under the same original magnification (325).
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possible 193 alleles (49%), indicating that allelic imbalance is a
male-specific trait.
DISCUSSION
In the present study, we genetically manipulated mtDNA
copy number in the male and female germline of the mouse to
determine the thresholds for fertilization and normal embryonic
development. We demonstrate that mtDNA copy number can
be reduced by an order of magnitude in the female germline
without affecting fertilization or preimplantation development;
however, a threshold of 40 000–50 000 mtDNA copies exists
for normal postimplantation embryonic development. In the
male germline, a threefold reduction in mtDNA copy number
does not significantly affect sperm function.
Low mtDNA Content Does Not Prevent Fertilization
Although the generation of ATP by oxidative phosphory-
lation clearly is essential for sperm motility [52], our results
demonstrate that reduced mtDNA copy content in sperm from
Tfam heterozygous males does not impede fertilization. Tfam
heterozygous males have sperm counts and motility parameters
indistinguishable from those of their wild-type littermates, even
though sperm from these animals contain threefold less
mtDNA. Based on studies reporting an average of 100 mtDNA
copies/sperm cell [54, 55], this would mean that mature murine
sperm can function normally with as few as 33 copies of
mtDNA. Further studies are required to define the minimal
copy number requirements for both spermatogenesis and
fertilization of the egg, but our results indicate that mature
murine sperm contain more than the necessary number of
mitochondrial genomes required to power their movement.
Supporting this idea is a study demonstrating that mouse
mtDNA molecules with large-scale deletions cause male-
related infertility only when the mutant load is high [53]. In
these mito-mice, impaired spermatogenesis and sperm number
and motility begin to manifest once the mutant load exceeds
73%, presumably leaving an estimated 27 functional copies of
mtDNA in the mature sperm (similar to that predicted in
Tfamþ/ males of the present study). However, to what degree
changes in behavior contribute to this decreased reproductive
capacity is unclear given the incapacitating nature of the
mitochondrial myopathy, the severity of which increases as a
function of mutational load.
It is tempting to propose a critical mtDNA threshold for
sperm function and, perhaps, male fertility based on these data.
However, we caution against this impulse, because the
decrease of mtDNA copy number in sperm from Tfam
heterozygous animals also extends to the testes and caudal
epididymis. The development of the soma and germline in both
sexes is deeply intertwined at virtually all stages of
gametogenesis, and the maturation of sperm is critically
dependent upon proper development and function of both the
Sertoli and Leydig cell populations in the testes. In addition,
fertilization is also contingent upon proper development of the
male reproductive tract. Defining the crucial threshold of
mtDNA content in the sperm will not be so straightforward
given the intricate interplay between germline and soma. We
FIG. 4. Embryo transfer and developmental outcome. Bar graphs
represent the mean frequency of implantation and survival, scored by
normal morphological and developmental progression following embryo
transfer of nonbiopsied controls, Low-copy group embryos (n ¼ 19;
mtDNA copy number range, 3558–55 000), and high-copy group embryos
(n ¼ 15; mtDNA copy number range, 56 000–160 000). Low-copy and
high-copy groups were determined to be statistically different (P . 0.001),
but the developmental outcome between the nonbiopsied control
embryos and the high-copy group were not (P ¼ 0.52).
FIG. 5. Measurement of sperm function and allelic bias in Tfam
heterozygous males. Standard measures of sperm motility (average path
velocity [VAP], progressive velocity [VSL], track speed [VCL], amplitude
of lateral head displacement [ALH], beta cross frequency [BCF], measure
of the departure of the cell path from a straight line [STR], measure of the
departure of the cell track from a straight line [LIN], and percentage
motility [Percent Motile]) and sperm count were assessed in caudal
epididymal samples from Tfam heterozygous males (A). Bar graphs
represent the results as a percentage of wild-type littermate controls of
VAP. No statistically significant differences (Student t-test) were observed
between groups for any of the measurements. A paternal transmission bias
for the deleted Tfam allele from Tfamþ/ males was observed in these
sperm samples as well as in the offspring of recessive testcrosses (B).
Floxed Tfam, wild-type Tfam, and maternally transmitted deleted Tfam
alleles segregated in mendelian fashion (data not shown).
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therefore propose that the mtDNA content of both mature
sperm and reproductive tract tissues is in excess of that
required for normal gametogenesis. This hypothesis is
consistent with our observation of allelic imbalance in sperm
generated from Tfam heterozygous males (either Tfam fl/ or
Tfamþ/) and the offspring generated from recessive testcross-
es. Male transmission of a deleted Tfam allele occurs more
often than would be predicted by chance alone (P , 0.0001),
suggesting that the diminished content of mtDNA accompa-
nying that deleted allele exercises some kind of functional
advantage at some point during spermatogenesis. It is not
immediately evident why fewer mitochondrial genomes would
be advantageous to developing spermatozoa, but it appears that
a down-regulation of both POLG and TFAM has been selected
for in the evolution of the male germline, ultimately resulting in
a marked reduction of mtDNA copy number during spermato-
genesis [9, 10]. Oligospermic and asthenozoospermic men
have sperm that contain significantly elevated levels of mtDNA
[35, 56], prompting the hypothesis that reduced copy number
in sperm decreases the likelihood of ROS-mediated damage to
mtDNA, effectively mitigating potentially deleterious effects
on sperm function. However, little compelling evidence
supports the ROS hypothesis, and if an upper limit of mtDNA
content in mature spermatozoa truly exists, its successful
definition will likely rest in the genetic manipulation of animal
models with more uniform nuclear genetic backgrounds.
Manipulation of mtDNA copy number in the female
germline allowed us to vary mtDNA copy number to a much
greater degree. Despite severe reductions in mtDNA copy
number in mature oocytes and cleavage-stage embryos,
Tfamfl/þ;Zp3-Creþ females produced normal numbers of
fertilized oocytes and cleavage-stage embryos. We failed to
connect developmental asynchrony in the preimplantation
embryo to mtDNA levels in embryos generated from either
the germline-specific Tfamþ/ deletions or Tfamþ/ heterozy-
gotes, both of which generated litter sizes and numbers similar
to those of controls. These data strongly indicate that low
mtDNA copy number in the ovulated oocyte does not
negatively impact fertilization or preimplantation development.
We conclude that the checkpoints for implantation, cleavage,
fertilization, and ovulation are not strictly regulated by
mitochondrial metabolism or copy number.
Developmental Threshold of mtDNA
and Postimplantation Viability
Several reports of high mitochondrial number estimated in
oocytes from a variety of mammals led to the notion of a
critical threshold of mtDNA copy number for the successful
fertilization and development of the embryo. It seems
reasonable to speculate that the biological range in mtDNA
content of the mature oocyte represents the viable amount that
has been empirically determined by mammalian evolution. In
humans, estimates of mtDNA copy number in presumably
healthy, metaphase II human oocytes range from 50 000 to
1 500 000 [33, 35, 57–59]. This range is much greater than
what we observed in mice (range, 11 000–428 000 copies/
embryo) (Fig. 1), but the low end of the distribution in mice
coincides with the human data. In fact, we found very few
presumably viable preimplantation embryos to contain less
than 50 000 copies of mtDNA and only 3 out of 219 (1.4%) to
contain fewer than 40 000 copies of mtDNA (these three
embryos contained 11 000, 24 000, and 30 000 copies,
respectively). To test whether the observed low end of this
distribution represents a functionally relevant critical threshold,
we determined mtDNA copy number by blastomere biopsy in
embryos derived from transgenic females carrying a deleted
copy of Tfam and then transferred these blastocysts to recipient
surrogate females. Despite the invasive nature of this
procedure, greater than 90% of biopsied embryos were
successfully cultured to the blastocyst stage and transferred
to the uterine horns of pseudopregnant recipient females. Of
these cultured embryos with mtDNA levels above the
hypothetical critical threshold, approximately 60% implanted
and developed normally (compared with an 80% success rate in
unmanipulated control embryos). We attribute this (not
statistically significant) difference to the invasiveness of the
manipulations that require disruption of the zona pellucida, the
biopsy of individual blastomeres, and lengthy in vitro culture.
Therefore, from these data, we conclude that the minimal
mtDNA copy number in the oocyte that is required for
postimplantation development and, hence, necessary for
embryonic development as a whole is on the order of
40 000–50 000 copies. Because mtDNA amplification does
not restart until the egg cylinder stage (;E6.0 in the mouse)
[13], embryos at the critical copy number threshold would be
predicted to contain an average of 22 mtDNAs per E6.5
embryonic cell if starting from 40 000 copies but an average of
90 if starting from the mean of 163 000 copies, and likely still
organized at from one to two mtDNA molecules per organelle
[12], based on the assumption that mtDNA copies are
continuously and uniformly distributed to the cells of the
developing postimplantation embryo. Nevertheless, from these
data, we conclude that the critical threshold for mtDNA copy
number in the mature mouse oocyte has evolved on the basis of
a functional consequence of mitochondrial insufficiency in the
postimplantation embryo, lending strength to the claim that
high mtDNA content in the mature female gametes is a genetic
mechanism ensuring the faithful transmission of these
organelles to all cells of the developing embryo.
Recently, it has been reported that experimental (physical)
depletion of mtDNA in single-cell embryos in cattle is
reversible up to the blastocyst stage [60], suggesting that low
levels of mtDNA in mature oocytes can be sensed and adjusted
upward in the preimplantation embryo. It is worth pointing out
that the mtDNA copy number in the depleted single-cell bovine
embryos in that study was three- to fourfold higher than the
mean copy number we measured in murine oocytes of the
present study. Although we could not perform longitudinal
measurements of mtDNA copy number in preimplantation
embryos during the present study, our observation that the
majority of cleavage-stage embryos with low mtDNA copy
numbers fail to complete postimplantation development
suggests that copy number compensation either does not occur
or is insufficient to overcome an low initial number of mtDNAs
in the single-cell embryo. Activation of mtDNA replication
appears to be part of normal biology in compaction/
blastulation-stage bovine embryos; however, in rodents,
restarting mtDNA replication occurs much later, during
postimplantation development, and signals/mechanisms to
compensate for low mtDNA copy number at the blastocyst
stage may not exist.
The upper end of the biological range in wild-type mouse
embryos does not appear to define a critical upper limit of
mtDNA copy number. Cox10þ/ heteroplasmic females
generate normal embryos with a mean copy number equal to
the highest copy number found in wild-type embryos (Fig. 2).
Our mean copy number measurements in embryos from
Cox10þ/ females (423 000 copies), Cox10 fl/þ;Zp3-Creþ
females (147 000 copies), and Cox10 fl/;Zp3-Cre (151 000
copies) indicate that an early, but not late, heterozygous
germline deletion of Cox10 leads to an up-regulation of
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mtDNA copy number, which is a typical compensatory
response to oxidative phosphorylation deficiency in many cell
types. Mitochondrial hyperproliferation has been documented
in affected tissues from patients with respiratory chain
disorders (e.g., COX deficiency) [61]. However, clinical
disease resulting from mutations in nuclear genes, such as
those that encode COX assembly factors, like COX10, are
inherited as an autosomal recessive trait, presumably because
of haplosufficiency [62–65]. Our observation that the soma and
germline of Cox10þ/ animals are clearly affected calls into
question the haplosufficiency of deleting an allele of Cox10.
We propose that the purported haplosufficiency of human
COX10, as evidenced by asymptomatic carriers, actually
reflects the residual function of the COX10 missense alleles
in the carriers. COX10/ null human embryos, like their
murine counterparts, likely succumb to spontaneous abortion
after implantation because of mitochondrial insufficiency.
Clinical and Evolutionary Relevance
The machinery involved in mtDNA maintenance, replica-
tion, and gene expression [66] has taken on new clinical
significance ever since mutations in the c-DNA polymerase,
dedicated to the replication of mtDNA, were proven to cause
progressive and adult-onset neuropathies [38]. Since then, both
loss-of-function and dominant negative mutations in POLG
have been associated with a variety of different metabolic
disorders, which include a recurring theme of mtDNA
depletion [67]. It is therefore not surprising that the first-
described Y955C dominant POLG mutations responsible for
disrupting the faithful replication of mtDNA in somatic tissues
also cause familial forms of female reproductive disorders [36,
37]. Anecdotal evidence of POLG patients seeking treatment
by way of in vitro fertilization or other assisted reproductive
technologies (M. Zeviani, personal communication) highlights
the importance of defining the critical threshold of mtDNA in
the general human population. As in the mouse, the normal
biological range of mtDNA copy number in the oocytes of
healthy fertile females likely defines the critical developmental
threshold. It is unlikely that the etiology of female-related
infertility is entirely attributable to insufficient levels of
mtDNA in the ovulated oocyte, but we propose that mtDNA
copy number should be examined when selecting ex vivo-
cultured embryos for uterine transfer, particularly when
blastomere biopsies are performed for the purposes of
preimplantation genetic diagnosis. Regardless of the mean
copy number, the lessons from our conditional knockout
mouse models indicate a broad biological range in mtDNA
copy number (Fig. 2). It would be prudent to transfer and
implant embryos with the highest likelihood of successful
development, which may be contingent upon mtDNA content
in some cases. Future studies will be needed to evaluate the
developmentally and clinically relevant threshold for mtDNA
in human embryos.
Irrespective of the minimal number of genomes required for
postimplantation development, the question remains: Why did
evolution insist upon a flurry of mitochondrial biogenesis
within the growing postnatal follicle to yield a mature oocyte
with tens or hundreds of thousands of copies of mtDNA if only
to delay resumption of mtDNA replication in early develop-
ment? Clearly, elevated levels of mtDNA are paramount to
neither fertilization nor cleavage. In addition, we have recently
demonstrated that the physical bottleneck created at the outset
FIG. 6. Critical threshold of mtDNA copy number during embryogenesis. The model for the evolution of mtDNA copy number in the female germline
indicates a critical threshold for mtDNA set at approximately 50 000 copies of mtDNA in the mature oocyte. Subthreshold embryos can progress normally
through cleavage but spontaneously abort after implantation. At E6.0, the stage at which mtDNA replication resumes, the cells of the embryo proper
would be expected to contain an average of 215 copies, assuming equal distribution of mtDNA in the cells of the developing embryos. Tfamfl/þ;Zp3-Creþ
oocytes (;18 000 copies of mtDNA; red) are successfully fertilized and progress through cleavage but fail to develop normally following implantation
because of mitochondrial insufficiency.
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of gametogenesis does not contribute significantly to the rapid
germline segregation of mtDNA sequence variants in a mouse
model [12].
It has been proposed that the logic behind the inflation and
deflation of mtDNA levels in the germline lies in the selective
elimination of severely deleterious mtDNA mutations [12, 68].
For the so-called filter for purifying selection to act during
embryonic (female) germline development, it must be set in the
context of low organelle content of mtDNA copy number in the
primordial germ cells. Beginning embryogenesis with high
levels of mtDNA and then halting replication during
preimplantation development would permit the incipient
primordial germ cell population to effectively filter out
severely deleterious mtDNA mutations [69]. In the absence
of an efficient DNA repair system, protective histones, and
recombination, the ROS-mediated damage of mtDNA would
cause the mitochondrial genome to rapidly accumulate
mutations and become entirely nonfunctional. Indeed, mice
lacking the proofreading function of POLG accumulate
somatic mtDNA mutational loads orders of magnitude greater
than those in wild-type mice and display symptoms of
premature ageing [39].
Evolution, hence, seems to have devised a system for
balancing elevated levels of mtDNA in the mature oocyte that
can sustain an exponential decrease in mitochondrial content
because of arrested mtDNA replication in early embryonic
development. This allows mtDNA levels to dip to those
required for purifying selection to act at the level of the
organelle in the developing germline, yet not so low that it
compromises postimplantation development (Fig. 6). Never-
theless, even the most severely deleterious mutations can avoid
this purifying filter, which may require several generations of
selection to be completely eliminated [70]. In fact, the majority
of inherited forms of mtDNA diseases in humans, which occur
at a frequency of 1 in 5000 [71, 72], are caused by mutations
that are not effectively eliminated by this system. The
mechanism responsible for the elimination of mtDNA
mutations has yet to be identified, but the study of spontaneous
mutations in the germlines of mice carrying an error-prone
mtDNA polymerase have led us to advance a hypothesis that
germline selection against severe mutations acts at the level of
the organelle. We have proposed that a functional discrepancy
between mitochondria carrying wild-type versus mutated
genomes exerts a slow, but consistent, advantage during the
mitotic divisions of the developing germline. We submit that
the selective elimination of severely deleterious mutations
would be most efficient when the mitochondrial content of
mtDNA is lowest, because clear differences in organelle fitness
would manifest more quickly, particularly during the constant
replication of mtDNA needed to keep step with the mitotic
divisions of the germline during oogenesis. If selection were
based on an indicator of mitochondrial function (e.g.,
membrane potential), which could be compromised by severe
mtDNA mutations, the embryonic increase in the number of
cells and mitochondrial genomes would provide a continuous
opportunity to ensure that the developing germline is populated
by the fittest mitochondria. Experimental validation of whether
the filter for purifying selection of severe mtDNA mutations is,
in fact, contingent upon a physical mtDNA bottleneck in
embryogenesis may provide clues to the mechanistic basis of
selection.
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